Type / Class
Equity / Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares
Shares outstanding
791M
Number of holders
48
Total 13F shares, excl. options
63.6M
Shares change
-2.69M
Total reported value, excl. options
$84M
Value change
+$2.51M
Put/Call ratio
0.07
Number of buys
13
Number of sells
-29
Price
$1.32

Significant Holders of Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) as of Q2 2023

63 filings reported holding MREO - Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares as of Q2 2023.
Mereo BioPharma Group plc - Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares (MREO) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 63.6M shares of 791M outstanding shares and own 8.04% of the company stock.
Largest 10 shareholders include Rubric Capital Management LP (11.6M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (7.36M shares), Rock Springs Capital Management LP (7.04M shares), MANGROVE PARTNERS (5.53M shares), 683 Capital Management, LLC (5.4M shares), ALKEON CAPITAL MANAGEMENT LLC (3.74M shares), BAKER BROS. ADVISORS LP (3.55M shares), Tejara Capital Ltd (3.04M shares), Boxer Capital, LLC (2.25M shares), and GOLDMAN SACHS GROUP INC (1.98M shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.